C肽/胰岛素摩尔比对区分A型胰岛素抵抗综合征与2型糖尿病的效用
回顾性分析18例A型胰岛素抵抗综合征(IRS)与126例2型糖尿病患者75g口服葡萄糖耐量试验(OGTT)中C肽反应性(CPR)/免疫反应性胰岛素(IRI)摩尔比。A型IRS患者IRI显著更高、CPR/IRI摩尔比显著更低;该比值在基线、1小时、2小时的ROC曲线下面积分别为0.997、0.999、0.997,敏感性和特异性均高于单用IRI,可能作为早期准确诊断A型IRS的临床标志物。
要点
- A型IRS患者IRI水平显著高于2型糖尿病,CPR/IRI摩尔比显著低于2型糖尿病。
- CPR/IRI摩尔比在OGTT基线、1小时、2小时的AUC分别为0.997、0.999、0.997。
- 该比值诊断性能不受体重指数或高胰岛素血症严重程度影响,敏感性特异性优于单用IRI。
核心结论
- CPR/IRI摩尔比在基线和OGTT期间对区分A型IRS与2型糖尿病的敏感性和特异性均高于单用IRI水平。
- 该比值可能作为早期准确诊断A型IRS的可靠临床标志物。
研究设计与样本
- 回顾性分析18例A型IRS患者和126例2型糖尿病患者在75g口服葡萄糖耐量试验(OGTT)中测定的CPR和IRI水平。
- 采用受试者工作特征(ROC)曲线分析评估CPR/IRI摩尔比和IRI水平的诊断性能。
主要发现
- A型IRS患者IRI水平显著高于2型糖尿病患者,CPR/IRI摩尔比显著低于2型糖尿病患者。
- CPR/IRI摩尔比在OGTT基线、1小时、2小时的ROC曲线下面积分别为0.997(敏感性100%,特异性99.2%)、0.999(敏感性100%,特异性97.6%)、0.997(敏感性100%,特异性95.1%)。
- CPR/IRI摩尔比的诊断性能不受体重指数或高胰岛素血症严重程度影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type A insulin resistance syndrome (IRS), characterized by impaired insulin receptor function due to variants of the insulin receptor gene, manifests as severe insulin-resistant diabetes. Differentiation of type A IRS from type 2 diabetes on the basis of hyperinsulinemia can be challenging. Given the association between insulin receptor dysfunction and reduced insulin clearance, we evaluated the potential of the circulating C-peptide reactivity (CPR)/immunoreactive insulin (IRI) molar ratio, a marker of insulin clearance, for distinguishing type A IRS from type 2 diabetes. METHODS: We retrospectively analyzed CPR and IRI levels measured during a 75-g oral glucose tolerance test (OGTT) in 18 individuals with type A IRS and 126 with type 2 diabetes. Receiver operating characteristic (ROC) curve analysis was performed to determine the diagnostic performance of the CPR/IRI molar ratio and IRI levels. RESULTS: IRI levels were significantly higher and the CPR/IRI molar ratio significantly lower in individuals with type A IRS compared with those with type 2 diabetes. The area under the ROC curve for the CPR/IRI molar ratio at baseline, 1 hour, and 2 hours after OGTT initiation was 0.997 (sensitivity 100%, specificity 99.2%), 0.999 (sensitivity 100%, specificity 97.6%), and 0.997 (sensitivity 100%, specificity 95.1%), respectively. The CPR/IRI molar ratio demonstrated robust diagnostic performance regardless of body mass index or hyperinsulinemia severity. CONCLUSION: The CPR/IRI molar ratio, both at baseline and during OGTT, exhibited higher sensitivity and specificity than IRI levels alone for distinguishing type A IRS from type 2 diabetes. This ratio may serve as a reliable clinical marker for early and accurate diagnosis of type A IRS.
引用
- Nishikage S, Hirota Y, Takayoshi T, et al. Utility of the C-Peptide/Insulin Molar Ratio for Distinguishing Type A Insulin Resistance Syndrome From Type 2 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 39873375. doi:10.1210/clinem/dgaf043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。